Surgical treatment of metastatic germ cell cancer.
Germ cell cancer
Metastatic germ cell cancer
Retroperitoneal lymphnode dissection
Retroperitoneal surgery
Journal
Asian journal of urology
ISSN: 2214-3882
Titre abrégé: Asian J Urol
Pays: Singapore
ID NLM: 101699720
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
26
11
2019
revised:
28
02
2020
accepted:
14
04
2020
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
18
5
2021
Statut:
ppublish
Résumé
Among young men between the ages of 15 and 40 years, germ cell cancer is the most common solid tumor [1]. The worldwide incidence of germ cell cancer is 70 000 cases. Compared to all solid tumors of men, germ cell cancer accounts for 1% of all male tumors. Nevertheless, the mortality of this rare tumor entity is about 13% since 9507 patients died worldwide of germ cell cancer. The improvement in survival of germ cell cancer patients is due to a multimodal treatment of germ cell cancer including cisplatin-based chemotherapy and surgery leading to higher cure-rates even in advanced stages [1], whereas the increasing incidence of germ cell cancers cannot be thoroughly explained. In this article we review the current indications for surgery in metastatic germ cell cancers, highlight the strength and weaknesses of techniques and indications and raise the question how to improve surgical treatment in metastatic germ cell cancer.
Identifiants
pubmed: 33996470
doi: 10.1016/j.ajur.2020.05.007
pii: S2214-3882(20)30033-3
pmc: PMC8099653
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
155-160Informations de copyright
© 2021 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.
Références
Urology. 2019 Feb;124:174-178
pubmed: 30296502
Eur Urol. 2008 Mar;53(3):497-513
pubmed: 18191015
Ann Oncol. 2016 May;27(5):875-9
pubmed: 26861605
J Clin Oncol. 2007 Dec 10;25(35):5597-602
pubmed: 18065732
J Clin Oncol. 1995 Nov;13(11):2700-4
pubmed: 7595727
J Natl Compr Canc Netw. 2015 Jun;13(6):772-99
pubmed: 26085393
Urol Clin North Am. 2019 Aug;46(3):363-376
pubmed: 31277731
Clin Genitourin Cancer. 2018 Apr;16(2):e307-e313
pubmed: 29104087
Front Surg. 2019 Jan 17;5:80
pubmed: 30705885
J Clin Oncol. 2004 Feb 1;22(3):464-7
pubmed: 14752068
Br J Cancer. 2006 Mar 27;94(6):820-7
pubmed: 16508636
Urol Oncol. 2019 Mar;37(3):209-218
pubmed: 30446455
Eur Urol. 2015 Dec;68(6):1054-68
pubmed: 26297604
J Clin Oncol. 2010 Apr 1;28(10):1706-13
pubmed: 20194867
J Clin Oncol. 2005 Apr 20;23(12):2781-8
pubmed: 15837993
Cancer. 2002 Aug 1;95(3):520-30
pubmed: 12209744
Eur J Cancer. 2000 Mar;36(4):472-5
pubmed: 10717522
J Clin Oncol. 2017 Nov 1;35(31):3525-3528
pubmed: 28854068
J Clin Oncol. 2008 Jun 20;26(18):2966-72
pubmed: 18458040
J Urol. 2019 Aug;202(2):272-281
pubmed: 31059667
Eur Urol. 2009 Jan;55(1):217-24
pubmed: 18926622
Urol Clin North Am. 2019 Aug;46(3):389-398
pubmed: 31277733
Oncol Res Treat. 2018;41(6):370-378
pubmed: 29772568
Ann Oncol. 2018 Feb 1;29(2):341-346
pubmed: 29140422
Eur Urol. 2012 Nov;62(5):867-76
pubmed: 22938868
Urologe A. 2013 Nov;52(11):1547-8, 1550-5
pubmed: 24126502
Urol Oncol. 2019 Nov;37(11):809.e9-809.e18
pubmed: 31540832
Can Urol Assoc J. 2016 May-Jun;10(5-6):204-209
pubmed: 27713801
Ann Oncol. 2013 Oct;24 Suppl 6:vi125-32
pubmed: 24078656
Cancer. 2007 Sep 15;110(6):1235-40
pubmed: 17665498
J Urol. 2007 Mar;177(3):937-42; discussion 942-3
pubmed: 17296380
J Clin Oncol. 2008 Dec 1;26(34):5524-9
pubmed: 18936477
World J Urol. 2017 Aug;35(8):1185-1190
pubmed: 28004146
Am Soc Clin Oncol Educ Book. 2018 May 23;38:324-329
pubmed: 30231348
J Clin Oncol. 1997 Feb;15(2):594-603
pubmed: 9053482
Urol Clin North Am. 2015 Aug;42(3):359-68
pubmed: 26216823